Lakewood-Amedex Biotherapeutics, Inc. LABT
0.20 USD +0.01 (+5.41%)
At closeNov 4, 2026, 4:40 AM EST
0.18 -0.02 -7.69%
Pre-market · Nov 4, 4:40 AM ET
0.1711 Day range 0.2046
0.17 52-week range 98.20
- YTD
- -99.77%
- 1 year
- -99.77%
Financial health
FMP rating
C+2 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 4
Valuation
P/E -31.3×
FY 2023 5y median -12.5× FY 2025
P/S 0.0×
FY 2023 5y median 0.0× FY 2025
P/B -61.4×
FY 2023 5y median 0.0× FY 2025
P/FCF -62.0×
FY 2023 5y median 0.0× FY 2025
EV/EBITDA -33.6×
FY 2023 5y median 0.0× FY 2025
EV/Sales 0.0×
FY 2023 5y median 0.0× FY 2025
FCF Yield -1.6%
FY 2023 5y median 0.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2023 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2023 5y median 0.0% FY 2025
ROE 195.9%
FY 2023 5y median 0.0% FY 2025
ROIC 1240.1%
FY 2023 5y median 0.0% FY 2025
ROA -798.9%
FY 2023 5y median 0.0% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2023 FY 2025
Operating Income 6.3%
FY 2023 FY 2025
EPS (diluted) 60.2%
FY 2023 FY 2025
Free Cash Flow 0.0%
FY 2023 FY 2025
Financial Health
Current Ratio 0.1×
FY 2023 5y median 0.0× FY 2025
Quick Ratio 0.1×
FY 2023 5y median 0.0× FY 2025
Debt / Equity -0.8×
FY 2023 5y median 0.0× FY 2025
Net Debt / EBITDA -0.4×
FY 2023 5y median 0.0× FY 2025
Interest Coverage -37.4×
FY 2023 5y median -805× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31